![Toru Sato](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Toru Sato
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Sonire Therapeutics, Inc. (TY)
![]() Sonire Therapeutics, Inc. (TY) Medical SpecialtiesHealth Technology Sonire Therapeutics, Inc. (TY) is a company based in Tokyo, Japan. The Japanese company specializes in developing a next-generation ultrasonic guide ultrasonic ultrasonic treatment device using acoustic engineering (ultrasonic) technology created from academia, which conducts cutting-edge research. The device uses high-intensity focused ultrasound (HIFU) and is designed to be used under ultrasonic guidance. The company was founded in 2020 and the CEO is Toru Sato.
2
| Holding Company | Medical Specialties | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Toru Sato
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Fast Track Initiative, Inc.
![]() Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States. | Investment Managers | Private Equity Analyst | |
Rin Institute, Inc.
![]() Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Japan | 3 |
Sektoral
Finance | 2 |
Health Technology | 2 |
Operativ
Director/Board Member | 3 |
Private Equity Analyst | 1 |
Chief Operating Officer | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Hiroko Kimura | 3 |
Jun Okamoto | 1 |